Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volitinib and docetaxel in advanced gastric adenocarcinoma
NCT02447380Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jul 2017
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
A Phase 2 trial of savolitinib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Jul 2017; status: completed.
02
Drugs
savolitinib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02447380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447380.